CSL CMXHF Stock
CSL Price Chart
CSL CMXHF Financial and Trading Overview
| CSL stock price | 164.51 USD |
| Previous Close | 207.45 USD |
| Open | 187.69 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 187.69 - 195.53 USD |
| 52 Week Range | 167.21 - 217.82 USD |
| Volume | 268 USD |
| Avg. Volume | 292 USD |
| Market Cap | 90.56B USD |
| Beta (5Y Monthly) | 0.217241 |
| PE Ratio (TTM) | 43.556843 |
| EPS (TTM) | 5.45 USD |
| Forward Dividend & Yield | 2.24 (1.08%) |
| Ex-Dividend Date | March 9, 2023 |
| 1y Target Est | N/A |
CMXHF Valuation Measures
| Enterprise Value | 112.85B USD |
| Trailing P/E | 43.556843 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.736977 |
| Price/Book (mrq) | 5.774886 |
| Enterprise Value/Revenue | 9.642 |
| Enterprise Value/EBITDA | 32.75 |
Trading Information
CSL Stock Price History
| Beta (5Y Monthly) | 0.217241 |
| 52-Week Change | 7.84% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 217.82 USD |
| 52 Week Low | 167.21 USD |
| 50-Day Moving Average | 200.6 USD |
| 200-Day Moving Average | 194.95 USD |
CMXHF Share Statistics
| Avg. Volume (3 month) | 292 USD |
| Avg. Daily Volume (10-Days) | 130 USD |
| Shares Outstanding | 482.37M |
| Float | 481.13M |
| Short Ratio | N/A |
| % Held by Insiders | 0.40% |
| % Held by Institutions | 35.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.25 |
| Trailing Annual Dividend Yield | 1.08% |
| 5 Year Average Dividend Yield | 107.00% |
| Payout Ratio | 0.5157 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 18.09% |
| Operating Margin (ttm) | 25.38% |
| Gross Margin | 52.52% |
| EBITDA Margin | 29.44% |
Management Effectiveness
| Return on Assets (ttm) | 6.30% |
| Return on Equity (ttm) | 13.37% |
Income Statement
| Revenue (ttm) | 11.7B USD |
| Revenue Per Share (ttm) | 24.31 USD |
| Quarterly Revenue Growth (yoy) | 18.89% |
| Gross Profit (ttm) | 5.73B USD |
| EBITDA | 3.45B USD |
| Net Income Avi to Common (ttm) | 2.12B USD |
| Diluted EPS (ttm) | 4.31 |
| Quarterly Earnings Growth (yoy) | -7.79% |
Balance Sheet
| Total Cash (mrq) | 1.51B USD |
| Total Cash Per Share (mrq) | 3.13 USD |
| Total Debt (mrq) | 12.12B USD |
| Total Debt/Equity (mrq) | 67.77 USD |
| Current Ratio (mrq) | 2.218 |
| Book Value Per Share (mrq) | 32.508 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.18B USD |
| Levered Free Cash Flow (ttm) | -113812496 USD |
Profile of CSL
| Country | United States |
| State | VIC |
| City | Parkville |
| Address | 45 Poplar Road |
| ZIP | 3052 |
| Phone | 61 3 9389 1911 |
| Website | https://www.csl.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 30000 |
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Q&A For CSL Stock
What is a current CMXHF stock price?
CSL CMXHF stock price today per share is 164.51 USD.
How to purchase CSL stock?
You can buy CMXHF shares on the OTC Markets OTCQX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for CSL?
The stock symbol or ticker of CSL is CMXHF.
Which industry does the CSL company belong to?
The CSL industry is Biotechnology.
How many shares does CSL have in circulation?
The max supply of CSL shares is 484.21M.
What is CSL Price to Earnings Ratio (PE Ratio)?
CSL PE Ratio is 30.18532200 now.
What was CSL earnings per share over the trailing 12 months (TTM)?
CSL EPS is 5.45 USD over the trailing 12 months.
Which sector does the CSL company belong to?
The CSL sector is Healthcare.